Clinical Trials Browser

Phase 1 × Terminated × rovalpituzumab tesirine × Clear all

NCT02819999 2020-03-12

A Study of Rovalpituzumab Tesirine (SC16LD6.5) in the Frontline Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Phase 1 Terminated

Small Cell Lung Carcinoma